Evidence map›Paper›PMID 42536416›Full record

ArticleBioinformatics (Oxford, England)2026

Accelerating inference in genomic and proteomic foundation models via speculative decoding.

Kimonas Provatas, Aris Karatzikos, Charalampos Koilakos, Michail Patsakis, Alexandros Tzanakakis, Akshatha Nayak, Georgios A Pavlopoulos, Ioannis Mouratidis, Evangelos Ioannis Avgoulas, Ilias Georgakopoulos-Soares

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Kimonas ProvatasDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Paediatric Research Institute, Austin, TX 78723, United States.
Aris KaratzikosDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Paediatric Research Institute, Austin, TX 78723, United States.
Charalampos KoilakosDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Paediatric Research Institute, Austin, TX 78723, United States.
Michail PatsakisDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Paediatric Research Institute, Austin, TX 78723, United States.
Alexandros TzanakakisDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Paediatric Research Institute, Austin, TX 78723, United States.
Akshatha NayakDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Paediatric Research Institute, Austin, TX 78723, United States.
Georgios A PavlopoulosInstitute for Fundamental Biomedical Research, BSRC "Alexander Fleming", Vari, 16672, Greece.ORCID 0000-0002-4577-8276
Ioannis MouratidisDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Paediatric Research Institute, Austin, TX 78723, United States.
Evangelos Ioannis AvgoulasIndependent Researcher, Athens, 15562, Greece.
Ilias Georgakopoulos-SoaresDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Paediatric Research Institute, Austin, TX 78723, United States.ORCID 0000-0003-3641-1488

Funding

Harnessing the Power of Kmers: Concepts and Methods for Genomic and Proteomic ResearchR35GM155468 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI Ilias Georgakopoulos-Soares · 2024 to 2026
$1.2M
National Institute of General Medical Sciences of the National Institutes of Health R35GM155468NIGMS NIH HHS R35 GM155468
6 · The paper itself

Abstract

motivationGenomic and protein foundation models (GFMs and PFMs) have demonstrated strong performance in learning the language of DNA and proteins, but their use in large-scale sequence generation is limited by the latency of autoregressive decoding. Because every token triggers a forward pass of a large Transformer, whose inference is relatively slow, long-sequence generation quickly becomes costly.

resultsIn this work we adapt speculative decoding to a representative GFM: the DNA model DNAGPT and two representative PFMs: ProGen2 and ProtGPT2. We implement a probabilistic variant of speculative decoding, in which a lightweight draft model proposes short token spans and a larger target model verifies or corrects them in parallel, while preserving the target model's sampling distribution. Across all three models we systematically study the effect of speculation window length, temperature, draft architecture and prompt length, and we benchmark tokens per second over multiple runs per configuration. Speculative decoding yields consistent speedups over standard key-value cached decoding, with maximum observed speedup reaching 100% increase, while average gains across models ranging between 20% and 40% (e.g. 1.2×-1.4×), without changing the underlying target model predictions. Our results show that speculative decoding is a practical and model-agnostic strategy for accelerating genomic and proteomic sequence generation without sacrificing prediction quality. AVAILABILITY AND IMPLEMENTATION: All code and results are freely available at https://github.com/Georgakopoulos-Soares-lab/BioSpecDec.

Indexed as

GenomicsModels, GeneticProteomicsProteinsProteins

Identifiers

PMID42536416
PMCPMC13474806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.